FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management
Dockets Entered On July 8, 2005
Table of Contents
Docket # Title
2001N-0548 Guidelines for Voluntary Nutrition Labeling of Raw Fruits
2004P-0013 Review safety of Nutropin Depot Injection, issue direction to Genentech Inc. to add warnings regarding diabetes in their safety literature, and consider amending 21 CFR 314.80(e) Postmarketing studies
2004P-0068 Establish specific bioequivalence requirements for oral products contanining desmopressin
2005N-0137 Levothyroxine Sodium Therapeutic Equivalence; Notice of Public Meeting
2005N-0276 prior notice and recordkeeping requirements (21 CFR Part 1,subpart I and J) to food samples for quality assurance,research, or analysis purposes
2005P-0170 ANADA for a generic ivermectin soft chew that differs in dosage form for horses
2005P-0277 ANADA Suitability for generic version of EXCENEL RTU, ceftiofur hydrochloride sterile suspension
2005P-0278 prior notice of imports (21 CFR part 1,subpart I) and establishment and maintenance of records (21CFR Part 1,subpart J).
2001N-0548 Guidelines for Voluntary Nutrition Labeling of Raw Fruits
EMC 15 Food Research Inc (California Kiwifruit Commission, Chilean Fresh Fruit Association, et al Vol #: 5
EMC 16 University of Hawaii at Manoa Vol #: 5
EMC 17 University of Hawaii at Manoa Vol #: 5
EMC 18 China WTO/TBT National Notification & Enquiry Center Vol #: 5
EMC 19 Produce for Better Health Foundation (PBH) Vol #: 5
EMC 20 U S Apple Association Vol #: 5
EMC 21 California Strawberry Commission (CSC) Vol #: 5
EMC 22 United Fresh Fruit and Vegetable Association Vol #: 5
EMC 23 National Watermelon Promotion Board Vol #: 5
2004P-0013 Review safety of Nutropin Depot Injection, issue direction to Genentech Inc. to add warnings regarding diabetes in their safety literature, and consider amending 21 CFR 314.80(e) Postmarketing studies
SUP 1 Consumer Vol #: 1
2004P-0068 Establish specific bioequivalence requirements for oral products contanining desmopressin
REF 1
Appendix 1
HFD-1 re: NDA 19-955 (Review of Two Pharmacokinetic Studies in a new NDA) Vol #: 1
2005N-0137 Levothyroxine Sodium Therapeutic Equivalence; Notice of Public Meeting
EXT 1 Abbott Laboratories Vol #: 1
2005N-0276 prior notice and recordkeeping requirements (21 CFR Part 1,subpart I and J) to food samples for quality assurance,research, or analysis purposes
CP 1 number not used Vol #: 1
2005P-0170 ANADA for a generic ivermectin soft chew that differs in dosage form for horses
PAV 1 HFV-1 to Intervet, Inc Vol #: 1
2005P-0277 ANADA Suitability for generic version of EXCENEL RTU, ceftiofur hydrochloride sterile suspension
ACK 1 HFA-305 to Pfizer Animal Health Vol #: 1
CP 1
Attachment
Pfizer Animal Health Vol #: 1
2005P-0278 prior notice of imports (21 CFR part 1,subpart I) and establishment and maintenance of records (21CFR Part 1,subpart J).
ACK 1 HFA-305 to National Institute of Oilseed Products Vol #: 1
CP 1 National Institute of Oilseed Products Vol #: 1

Page created on July 27, 2005 dp

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management